Announcements
On 6 June 2017, the World Health Organization (WHO) published updates to its ‘Essential Medicines List’ (EML). Read more here.

Extended deadline (from 1 July to 31 July) 2017 for call to submit papers on effectiveness and cost-effectiveness of screening and prevention of infectious diseases among newly arrived migrants in Europe. Read more here.

Eurosurveillance is on the updated list of the Directory of Open Access Journals and in the SHERPA/RoMEO database. Read more here.

Follow Eurosurveillance on Twitter: @Eurosurveillanc


Back to All Announcements
Previous Previous Next Next

Call for papers

Call for papers for a special issue on the epidemiology of leishmaniasis in Europe

Eurosurveillance invites authors to submit papers for a special issue on the surveillance and epidemiology of leishmaniasis in Europe.

Leishmaniasis, a vector-borne disease transmitted by sand flies, is endemic in southern European countries. Autochthonous cases in Europe are mainly due to infection with Leishmania infantum, which causes zoonotic visceral and cutaneous leishmaniasis. L. tropica, endemic only in Greece with a sporadic pattern, causes anthroponotic cutaneous leishmaniasis. Dogs are the main reservoir for L. infantum. Most reported cases have visceral leishmaniasis. A publication in 2008, in Emerging Infectious Diseases [1], estimated that annually around 700 new clinical cases of leishmaniasis are reported in European Union (EU) countries. Asymptomatic cases are thought to be many more, with an estimated ratio of >100 asymptomatic:1 clinical case [2]. Many of the EU countries where the disease is endemic are tourist destinations and there is evidence that a number of leishmaniasis cases diagnosed in non-endemic countries are imported from within the continent. The disease is notifiable in a number of endemic and non-endemic countries in Europe; however, surveillance varies and under-reporting appears to be frequent, especially for the benign forms of cutaneous leishmaniasis.

The aim of the special issue is to contribute to the existing body of evidence and to make available data that can help paint a better picture of the epidemiological situation and burden of autochthonous leishmaniasis in Europe.

We invite interested scientists and public health experts to share their surveillance data, findings and views and submit original papers for peer review and possible publication.

Topics of interest include, but are not limited to:

  • results from surveillance of visceral and cutaneous leishmaniasis in endemic and non-endemic countries, including trends in age groups affected and the impact of HIV co-infection, organ transplantation, and therapies of immunological disorders on the development and outcome of disease;
  • information on the distribution of the vector and reservoir;
  • analysis of treatment-associated costs;
  • control measures implemented successfully to stop the spread of disease;
  •  issues related to the detection and identification of cases.

The submission deadline is 15 July 2012. If you would to submit a paper or ask for more information, please see our instructions for authors regarding article formats: http://www.eurosurveillance.org/Public/ForAuthors/ForAuthors.aspx#article and contact the editorial team at eurosurveillance@ecdc.europa.eu.


References

  1. Dujardin JC, Campino L, Cañavate C, Dedet JP, Gradoni L, Soteriadou K, et al. Spread of vector-borne diseases and neglect of Leishmaniasis, Europe. Emerg Infect Dis. 2008;14(7):1013-8.
  2. Michel G, Pomares C, Ferrua B, Marty P. Importance of worldwide asymptomatic carriers of Leishmania infantum (L. chagasi) in human. Acta Trop. 2011;119(2-3):69-75.


Back to All Announcements
Previous Previous Next Next

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN] - ©2007-2016. All rights reserved
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.